As filed with the Securities and Exchange Commission on February 5, 2021
Registration No. 333-201327
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Post-Effective Amendment No. 1
to
Form S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Walgreens Boots Alliance, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware | 47-1758322 | |
(State or other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
108 Wilmot Road, Deerfield, Illinois 60015
(Address and Zip Code of Principal Executive Offices)
Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan
Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan
(Full Title of the Plan)
Marco Pagni
Executive Vice President, Global Chief Administrative Officer and General Counsel
Walgreens Boots Alliance, Inc.
108 Wilmot Road
Deerfield, Illinois 60015
Telephone: (847) 315-3700
(Name, Address, and Telephone Number, including Area Code, of Agent for Service)
With a copy to:
Joseph B. Amsbary, Jr.
Walgreens Boots Alliance, Inc.
108 Wilmot Road
Deerfield, Illinois 60015
Telephone: (847) 315-3700
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
As permitted by Rule 429 under the Securities Act, the prospectus related to this Registration Statement also covers securities registered under Registration 333-198768 on Form S-8 and a new Registration Statement on Form S-8 with respect to the 2021 Plan (as defined below).
EXPLANATORY NOTE
On January 28, 2021 (the Effective Date), the stockholders of Walgreens Boots Alliance, Inc. (the Registrant) (File No. 1-36759) approved the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (the 2021 Plan). The total number of shares of the Registrants Common Stock, par value $0.01 per share (the Common Stock), that may be granted under the 2021 Plan includes, in addition to 65,000,000 new shares of Common Stock (on a new Registration Statement on Form S-8 filed on February 5, 2021), (i) the number of shares that remained available for issuance under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended and restated (the 2013 Plan) as of the Effective Date and (ii) the undelivered shares subject to outstanding awards granted under the 2013 Plan that become available for future awards under the 2021 Plan as provided for in the 2021 Plan (the shares described in (i) and (ii), the 2013 Plan Shares).
In accordance with Item 512(a)(1)(iii) of Regulation S-K and Compliance and Disclosure Interpretation 126.43, this Post-Effective Amendment No. 1 to Registration Statement No. 333-201327 (the Post-Effective Amendment) is hereby filed to cover the issuance of the 2013 Plan Shares pursuant to the 2021 Plan. This Post-Effective Amendment does not pertain to the other plans included in the original Registration Statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents heretofore filed with the Securities and Exchange Commission (the Commission) by the Registrant are incorporated herein by reference into this Registration Statement:
(1) | The Registrants Annual Report on Form 10-K for the fiscal year ended August 31, 2020, filed with the Commission on October 15, 2020; | |
(2) | The Registrants Quarterly Report on Form 10-Q for the quarterly period ended November 30, 2020, filed with the Commission on January 7, 2021; | |
(3) | The Registrants Current Reports on Form 8-K, filed with the Commission on September 17, 2020, October 30, 2020, December 28, 2020, January 8, 2021, February 1, 2021 and February 2, 2021 (excluding in each case any information furnished under Item 7.01); and | |
(4) | The description of the Registrants common stock contained in Amendment No. 2 to the Registrants Registration Statement on Form S-4 filed with the Commission on November 18, 2014, including any subsequent amendments or reports filed for the purpose of updating such description. |
All documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act), after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement indicating that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Notwithstanding the foregoing, unless specifically stated to the contrary, none of the information disclosed by the Registrant under Items 2.02 or 7.01 of any Current Report on Form 8-K, including the related exhibits under Item 9.01, that the Registrant may from time to time furnish to the Commission will be incorporated by reference into, or otherwise included in, this Registration Statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
Section 145 of Title 8 of the General Corporation Law of the State of Delaware (the DGCL), empowers a corporation, within certain limitations, to indemnify any person against expenses (including attorneys fees), judgments, fines and amounts paid in settlement and reasonably incurred by such person in connection with any suit or proceeding to which such person is a party by reason of the fact that such person is or was a director, officer, employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, as long as such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation. With respect to any criminal proceedings, such person must have had no reasonable cause to believe that his or her conduct was unlawful.
In the case of a proceeding by or in the right of the corporation to procure a judgment in its favor (e.g., a stockholder derivative suit), a corporation may indemnify an officer, director, employee or agent if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation; provided, however, that no person adjudged to be liable to the corporation may be indemnified unless, and only to the extent that, the Delaware Court of Chancery or the court in which such action or suit was brought determines upon application that, despite the adjudication of liability, in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court deems proper. A director, officer, employee or agent who is successful, on the merits or otherwise, in defense of any proceeding subject to the DGCLs indemnification provisions must be indemnified by the corporation for reasonable expenses incurred therein, including attorneys fees.
As permitted by the DGCL, the Registrants certificate of incorporation includes a provision that eliminates the personal liability of the Registrants directors for monetary damages for breach of fiduciary duty as a director, except for liability (1) for any breach of the directors duty of loyalty to the Registrant or its stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) under section 174 of the DGCL or (4) for any transaction from which the director derived an improper personal benefit.
As a result of this provision, the Registrants ability or that of the Registrants stockholders to successfully prosecute an action against a director for breach of his or her duty of care is limited. However, this provision does not affect the availability of equitable remedies such as an injunction or rescission based upon a directors breach of his or her duty of care. The Commission has taken the position that this provision will have no effect on claims arising under the federal securities laws.
In addition, the Registrants bylaws provide for mandatory indemnification rights, subject to limited exceptions, to any director, officer or certain other persons who (because of the fact that he or she is the Registrants director or officer) is involved in a legal proceeding of any nature. These indemnification rights include reimbursement for expenses incurred by the Registrants directors, officers or certain other persons in advance of the final disposition of a proceeding according to applicable law.
The Registrant also provides insurance from commercial carriers against certain liabilities that may be incurred by the Registrants directors and officers.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
* | Filed herewith. |
Item 9. Undertakings.
(a) The Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the Securities Act);
(ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and
(iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(b) The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrants annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plans annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Village of Deerfield, State of Illinois, on the 5th day of February, 2021.
WALGREENS BOOTS ALLIANCE, INC. | ||
By | /s/ James Kehoe | |
Name | James Kehoe | |
Title | Executive Vice President and Global Chief Financial Officer |
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Stefano Pessina, James Kehoe and Marco Pagni, and each of them, as such persons true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for such person and in such persons name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or such persons substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and dates indicated.
Signature |
Title |
Date | ||
/s/ Stefano Pessina |
Executive Vice Chairman and Chief Executive Officer (Principal Executive Officer) and Director | February 5, 2021 | ||
Stefano Pessina | ||||
/s/ James Kehoe |
Executive Vice President and Global Chief Financial Officer (Principal Financial Officer) | February 5, 2021 | ||
James Kehoe | ||||
/s/ Heather Dixon |
Senior Vice President, Global Controller and Chief Accounting Officer (Principal Accounting Officer) | February 5, 2021 | ||
Heather Dixon | ||||
/s/ James A. Skinner |
Executive Chairman | February 5, 2021 | ||
James A. Skinner | ||||
/s/ José E. Almeida |
Director | February 5, 2021 | ||
José E. Almeida | ||||
/s/ Janice M. Babiak |
Director | February 5, 2021 | ||
Janice M. Babiak | ||||
/s/ David J. Brailer |
Director | February 5, 2021 | ||
David J. Brailer | ||||
/s/ William C. Foote |
Director | February 5, 2021 | ||
William C. Foote | ||||
/s/ Ginger L. Graham |
Director | February 5, 2021 | ||
Ginger L. Graham | ||||
/s/ Valerie B. Jarrett |
Director | February 5, 2021 | ||
Valerie B. Jarrett | ||||
/s/ John A. Lederer |
Director | February 5, 2021 | ||
John A. Lederer | ||||
/s/ Dominic P. Murphy |
Director | February 5, 2021 | ||
Dominic P. Murphy | ||||
/s/ Nancy M. Schlichting |
Director | February 5, 2021 | ||
Nancy M. Schlichting |
Exhibit 5.1
SIDLEY AUSTIN LLP | ||
ONE SOUTH DEARBORN STREET | ||
CHICAGO, IL 60603 | ||
+1 312 853 7000 | ||
+1 312 853 7036 FAX | ||
AMERICA ASIA PACIFIC EUROPE |
February 5, 2021
Walgreens Boots Alliance, Inc.
108 Wilmot Road
Deerfield, IL 60015
Re: | Post-Effective Amendment No. 1 to Registration Statement on Form S-8 |
Ladies and Gentlemen:
We refer to the Post-Effective Amendment No. 1 (the Post-Effective Amendment) to Registration Statement No. 333-201327 on Form S-8 (the Registration Statement) being filed by Walgreens Boots Alliance, Inc., a Delaware corporation (the Company), with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the Securities Act), covering shares of Common Stock, $0.01 par value per share, of the Company (Common Stock), which may be issued under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (the 2021 Plan).
On January 28, 2021 (the Effective Date), the stockholders of the Company approved the 2021 Plan. The total number of shares of Common Stock that may be granted under the 2021 Plan includes, in addition to 65,000,000 new shares of Common Stock (included by the Company on a new Registration Statement on Form S-8 filed on February 5, 2021), (i) the number of shares that remained available for issuance under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended and restated (the 2013 Plan) as of the Effective Date and (ii) the undelivered shares subject to outstanding awards granted under the 2013 Plan that become available for future awards under the 2021 Plan as provided for in the 2021 Plan (the shares described in (i) and (ii), the 2013 Plan Shares).
This opinion letter is being delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.
We have examined the Post-Effective Amendment, the Registration Statement, the Companys Amended and Restated Certificate of Incorporation and Amended and Restated By-laws, the 2021 Plan, the resolutions adopted by the board of directors of the Company relating to the Registration Statement and the 2021 Plan and the proposal adopted by the stockholders of the Company relating to the 2021 Plan at the Companys 2021 Annual Meeting of Stockholders. We have also examined originals, or copies of originals certified to our satisfaction, of such agreements, documents, certificates and statements of the Company and other corporate documents and instruments, and have examined such questions of law, as we have considered relevant and necessary as a basis for this opinion letter. We have assumed the authenticity of all
Sidley Austin LLP is a limited liability partnership practicing in affiliation with other Sidley Austin partnerships.
Walgreens Boots Alliance, Inc.
February 5, 2021
Page 2
documents submitted to us as originals, the genuineness of all signatures, the legal capacity of all persons and the conformity with the original documents of any copies thereof submitted to us for examination. As to facts relevant to the opinions expressed herein, we have relied without independent investigation or verification upon, and assumed the accuracy and completeness of, certificates, letters and oral and written statements and representations of public officials and officers and other representatives of the Company.
Based on the foregoing, we are of the opinion that each 2013 Plan Share that is newly issued pursuant to the 2021 Plan will be validly issued, fully paid and non-assessable when: (i) the Post-Effective Amendment shall have become effective under the Securities Act; (ii) such 2013 Plan Share shall have been duly issued and delivered in accordance with the 2021 Plan; and (iii) certificates representing such 2013 Plan Share shall have been duly executed, countersigned and registered and duly delivered to the person entitled thereto against payment of the agreed consideration therefor (in an amount not less than the par value thereof) or, if any 2013 Plan Share is to be issued in uncertificated form, the Companys books shall reflect the issuance of such 2013 Plan Share to the person entitled thereto against payment of the agreed consideration therefor (in an amount not less than the par value thereof), all in accordance with the 2021 Plan.
This opinion letter is limited to the General Corporation Law of the State of Delaware. We express no opinion as to the laws, rules or regulations of any other jurisdiction, including, without limitation, the federal laws of the United States of America or any state securities or blue sky laws.
We hereby consent to the filing of this opinion letter as an Exhibit to the Registration Statement and to all references to our Firm included in or made a part of the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.
Very truly yours,
/s/ Sidley Austin LLP
Sidley Austin LLP
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Post-Effective Amendment No. 1 to Registration Statement No. 333-201327 on Form S-8 of our reports dated October 15, 2020, relating to the consolidated financial statements of Walgreens Boots Alliance, Inc. and subsidiaries (the Company) and the effectiveness of the Companys internal control over financial reporting appearing in the Annual Report on Form 10-K of the Company for the year ended August 31, 2020.
/s/ Deloitte & Touche, LLP |
Deloitte & Touche, LLP |
Chicago, Illinois |
February 5, 2021 |